av/pacira-pharmaceuticals--big.svg

NASDAQ:PCRX

Pacira BioSciences, Inc.

  • Stock

USD

Last Close

29.04

28/03 20:00

Market Cap

1.49B

Beta: 0.76

Volume Today

569.63K

Avg: 596.19K

PE Ratio

207.02

PFCF: 11.04

  • industry

    Drug Manufacturers / Specialty & Generic
  • exchange

    NASDAQ Global Select
  • website

    www.pacira.com
  • ipo date

    Feb 03, 2011
  • full time employees

    715
  • currency

    USD

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectab...Show More

Earnings

Earnings per Share (Estimate*)

-0.20.20.40.60.812015-02-242017-03-012019-02-282021-02-252023-02-28

Revenue (Estimate*)

50M100M150M200M2015-02-242017-03-012019-02-282021-02-252023-02-28

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.